NLRP3 and metabolic dysfunction-associated steatotic liver disease: Both NLRP6 and NLRP3 inflammasomes negatively regulate the progression of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) through the modulation of the gut microbiota [176].